albendazole has been researched along with transforming growth factor beta in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirayama, K; Kiyuna, S; Sato, Y; Satoh, M; Shiroma, Y; Takara, M; Toma, H | 1 |
| Bao, GS; Chen, G; Mo, JJ; Shi, DZ; Zhou, HX | 1 |
| Anuradha, R; Babu, S; Bhootra, Y; Dolla, C; Jagannathan, J; Kumaran, P; Munisankar, S; Nutman, TB | 1 |
3 other study(ies) available for albendazole and transforming growth factor beta
| Article | Year |
|---|---|
Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1.
Topics: Aged; Albendazole; Animals; Anthelmintics; Antibodies, Helminth; Feces; Female; Gene Expression Regulation; HTLV-I Infections; Humans; Immunocompromised Host; Immunoglobulin E; Immunoglobulin G; Interferon-gamma; Intestinal Diseases, Parasitic; Male; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Strongyloides stercoralis; Strongyloidiasis; Transforming Growth Factor beta; Treatment Failure | 2002 |
[Effect of combined pentoxifylline and albendazole against echinococcus multilocularis infection in mice].
Topics: Albendazole; Animals; Anthelmintics; Drug Therapy, Combination; Echinococcosis; Echinococcus multilocularis; Female; Interleukin-10; Interleukin-2; Mice; Pentoxifylline; Transforming Growth Factor beta; Treatment Outcome | 2006 |
IL-10- and TGFβ-mediated Th9 Responses in a Human Helminth Infection.
Topics: Adolescent; Adult; Albendazole; Antiparasitic Agents; Case-Control Studies; Female; Gene Expression Regulation; Humans; Interleukin-10; Ivermectin; Male; Middle Aged; Strongyloidiasis; T-Lymphocyte Subsets; Transforming Growth Factor beta; Young Adult | 2016 |